Skip to content
Riskpilot
← Back to search
Sign in
Get full access
PHARMA NORDIC AS
AS
Active
Org 929064909
5 Etg Storgata 38, 6002
Ålesund
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2022 · 4 years old
7 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
PHARMA NORDIC AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
2M
3M
5M
0M
2022
0M
2023
4M
2024
EBITDA
NOK millions
0M
-6M
-11M
-17M
-23M
-3M
2022
-8M
-167%
2023
-18M
-125%
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
85
158
4 113
Staff expenses
−0
−1 190
−2 853
EBITDA
−2 524
−7 556
−17 639
Depreciation & amort.
−0
−0
−47
EBIT
−2 524
−7 556
−17 686
Net financials
−13
−69
−364
Profit before tax
−2 536
−7 625
−18 049
Tax
−551
−1 639
−3 937
Net profit
−1 986
−5 986
−14 112
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
2 487
4 905
23 770
Equity
71
710
19 998
Long-term debt
0
0
1 658
Short-term debt
2 416
4 196
2 115
Total debt
2 416
4 196
3 773
Financial ratios
5-year trend
EBITDA margin
-428.8%
This company
15.8%
Market median
-2814% vs market
2022
2024
Equity ratio
84.1%
This company
38.2%
Market median
+120% vs market
2022
2024
Return on equity
-70.6%
This company
18.4%
Market median
-484% vs market
2022
2024
Net profit margin
-343.1%
This company
8.1%
Market median
-4336% vs market
2022
2024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
2022
2024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-02-24 – 2022-12-31
View
PDF
More on PHARMA NORDIC AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network